For the week ending Dec 6 2019 John Mandrola, MD comments on the following cardiology news and features stories:
Vernakalant Seems Safe, Effective for AF Cardioversion in Lead-up to FDA Advisory Panel
Cancer Patients, Survivors Face Increased Risk of Heart Disease Deaths
DAPA-HF: Heart Failure Toolbox Poised to Add a New Family of Drugs
DAPA-HF: Dapagliflozin Benefited Regardless of Age, Heart Failure Severity
Sacubitril/Valsartan Benefits Extend to HF With Mildly Reduced EF
Features:
© 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Dec 6, 2019 This Week in Cardiology Podcast - Medscape - Dec 06, 2019.
Comments